High dose rate brachytherapy in combination with external-beam radiotherapy for localised prostate cancer

4 Other NICE recommendations on brachytherapy

Further recommendations have been made as part of the NICE guideline on prostate cancer: diagnosis and management, which was published in May 2019, as follows:

Brachytherapy is not recommended for men with high-risk localised prostate cancer.

Clinical and cost-effectiveness evidence was reviewed in the development of this guideline which has led to this more specific recommendation. More information is available in the guideline. The interventional procedure guidance on high dose rate brachytherapy in combination with external-beam radiotherapy for localised prostate cancer remains current, and should be read in conjunction with the prostate cancer guideline.